Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study

The receptors for advanced glycation end products (RAGE) are increased in atherosclerotic plaques. Soluble (s)RAGE decreases, whereas the extracellular newly identified receptor for advanced glycation end prod...

Source: Lipids in Health and Disease - October 14, 2020 Category: Lipidology Authors: Eva O. Melin, Jonatan Dereke and Magnus Hillman Tags: Research Source Type: research